Medication info
Truempam Extended-Release Tablets 25/1000 mg (Empagliflozin, Metformin)

Truempam Extended-Release Tablets 25/1000 mg (Empagliflozin, Metformin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›25mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Boryung Pharmaceutical Co., Ltd.
Appearance
Orange oval-shaped extended-release film-coated tablets
Packaging
Domestic use - 30 tablets/bottle
Approval status
Active

MFDS item code 202501234 · Approved 2025.05.20 · Insurance code 641908690

Summary

Main use
Improvement of blood glucose control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For antidiabetic therapy, this medicine may be administered as 1 tablet once daily with a meal to patients taking empagliflozin 25mg and metformin hydrochloride (extended-release) 1000 mg. To reduce gastrointestinal adverse reactions caused by metformin, this medicine should be taken once daily with the evening meal. To maintain its extended-release properties, this medicine must be swallowed whole without splitting, crushing, grinding, or chewing. This medicine may not dissolve completely and may be excreted in the stool. It is not known whether the material excreted in the stool contains the active ingredient. If the patient repeatedly reports finding this medicine in the stool, the healthcare provider should assess whether blood glucose is adequately controlled (see Precautions for Use, 5. General Precautions). For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the initial recommended total daily dose when taking this medicine is empagliflozin 10 mg and the patient's current metformin dose. If empagliflozin 10 mg is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg. Patients switching from combination therapy with empagliflozin and metformin to this medicine should receive their current doses of empagliflozin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). As dose adjustment according to renal function may be necessary, assessment of renal function is recommended before and periodically during treatment with this medicine. No dosage adjustment is required in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 60 mL/min/1.73 ㎡]. In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≧ 45 mL/min and <60mL/min or estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73㎡ and <60mL/min/1.73㎡], this medicine may be used by adjusting the dose of metformin hydrochloride as follows, provided it is well tolerated and the patient has no other conditions that may increase the risk of lactic acidosis. - The starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily; therefore, do not initiate treatment with this medicine. The maximum daily dose of metformin hydrochloride is 1000mg. If creatinine clearance (CrCl) decreases to less than 45 ml/min or estimated glomerular filtration rate (eGFR) decreases to less than 45 ml/min/1.73㎡, discontinue this medicine immediately. In patients 75 years of age and older, consider renal function and the risk of volume depletion.

Ingredients

Manufacturer
Boryung Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in adults with type 2 diabetes mellitus

  • Type 2 diabetes with difficult blood sugar control
  • cardiovascular disease
View approved original text

This medication contains empagliflozin and metformin, and is used as an adjunct to diet and exercise for the control of blood sugar in adults with type 2 diabetes. It is particularly important for those with type 2 diabetes who do not achieve adequate blood sugar control and have cardiovascular diseases to be cautious about the occurrence of cardiovascular events. Therefore, it should be administered according to a healthcare professional's instructions and will help in maintaining appropriate blood sugar management.

How to take

Adult dose

For antidiabetic therapy, this medicine may be administered as 1 tablet once daily with a meal to patients taking empagliflozin 25mg and metformin hydrochloride (extended-release) 1000 mg. To reduce gastrointestinal adverse reactions caused by metformin, this medicine should be taken once daily with the evening meal. To maintain its extended-release properties, this medicine must be swallowed whole without splitting, crushing, grinding, or chewing. This medicine may not dissolve completely and may be excreted in the stool. It is not known whether the material excreted in the stool contains the active ingredient. If the patient repeatedly reports finding this medicine in the stool, the healthcare provider should assess whether blood glucose is adequately controlled (see Precautions for Use, 5. General Precautions). For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the initial recommended total daily dose when taking this medicine is empagliflozin 10 mg and the patient's current metformin dose. If empagliflozin 10 mg is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg. Patients switching from combination therapy with empagliflozin and metformin to this medicine should receive their current doses of empagliflozin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted as appropriate. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). As dose adjustment according to renal function may be necessary, assessment of renal function is recommended before and periodically during treatment with this medicine. No dosage adjustment is required in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60 mL/min or estimated glomerular filtration rate (eGFR) ≧ 60 mL/min/1.73 ㎡]. In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≧ 45 mL/min and <60mL/min or estimated glomerular filtration rate (eGFR) ≧ 45 mL/min/1.73㎡ and <60mL/min/1.73㎡], this medicine may be used by adjusting the dose of metformin hydrochloride as follows, provided it is well tolerated and the patient has no other conditions that may increase the risk of lactic acidosis. - The starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily; therefore, do not initiate treatment with this medicine. The maximum daily dose of metformin hydrochloride is 1000mg. If creatinine clearance (CrCl) decreases to less than 45 ml/min or estimated glomerular filtration rate (eGFR) decreases to less than 45 ml/min/1.73㎡, discontinue this medicine immediately. In patients 75 years of age and older, consider renal function and the risk of volume depletion.

Precautions

This medication is used for treating diabetes and helps in controlling blood sugar. While taking this medication, although rare, a serious condition called lactic acidosis can occur, so caution is needed. Lactic acidosis can be a dangerous condition where lactic acid accumulates in the body, so if symptoms appear, you must go to a hospital immediately. Hypoglycemia may occur when taken with other diabetes medications, so blood sugar level changes should be closely monitored. Patients with poor kidney function may be at risk when taking this medication, so regular kidney function tests are necessary, and the medication should be discontinued if kidney function falls below a certain level. It may be necessary to temporarily discontinue this medication during acute infections, dehydration, heart problems, or before and after severe injuries or surgeries. It is safest for women who are pregnant or might become pregnant not to take this medication. Safety and efficacy in children have not been established, so it is not recommended for those under 18 years of age. Elderly patients may have decreased kidney function, so dose adjustments and regular kidney function monitoring are necessary. Taking this medication with alcohol may be dangerous, so it is advisable to avoid drinking. During the course of taking this medication, genital infections or urinary tract infections may occur, so if symptoms arise, consult a healthcare professional immediately. If symptoms such as nausea, vomiting, abdominal pain, weakness, or difficulty breathing occur while taking this medication, consult a doctor promptly. This medication should be swallowed whole and not crushed or chewed, as it may appear intact in the stool, which is normal. Before undergoing surgery or tests using iodinated contrast agents, this medication should be discontinued, and it should only be resumed after confirming normal kidney function. This medication may interact with other drugs, so if you are taking other medications, be sure to inform your healthcare professional. In cases of overdose, serious side effects may occur, so adhere strictly to prescribed dosages, and if any unusual symptoms arise, visit a hospital immediately.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • decreased and deficiency of vitamin B12
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
Show 183 more
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • anorexia
  • constipation
  • abnormal liver function tests
  • hepatitis
  • altered taste
  • pruritus
  • rash
  • urticaria
  • erythema
  • angioedema
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • chronic gastritis
  • various neurological disorders
  • cerebral infarction
  • soft tissue infection
  • pneumonia
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • musculoskeletal pain
  • myocardial infarction
  • ketoacidosis
  • urosepsis
  • pyelonephritis
  • rash
  • urticaria
  • angioedema
  • necrotizing fasciitis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • colonic hemorrhage
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pulmonary tuberculosis
  • sepsis
  • subcutaneous abscess
  • adnexal abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • ureterolithiasis
  • acute kidney injury
  • hematuria
  • hyperactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • abnormal urination
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • dizziness
  • chest discomfort
  • chest pain
  • asthenia
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • hyperglycemia
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • musculoskeletal pain
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • glaucoma
  • macular fibrosis
  • ocular discomfort
  • conjunctival hyperemia
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • macular retinal detachment
  • eyelid edema
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • residual sputum
  • cough
  • epistaxis
  • allergic rhinitis
  • skin laceration
  • rib fracture
  • iliotibial band syndrome
  • angina pectoris
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery obstructive disease
  • anxiety
  • depression
  • sleep disturbance
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • otalgia
  • positional vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • diarrhea
  • dyspepsia
  • abdominal pain
  • nausea
  • gastritis
  • gastrointestinal disorder
  • nasopharyngitis
  • herpes zoster
  • dizziness
  • headache
  • chest discomfort
  • chest pain
  • asthenia
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • hyperglycemia
  • low back pain
  • diabetic retinopathy
  • dry eyes
  • cough
  • dyspnea
  • unstable angina
  • hypertension
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

Orange oval-shaped extended-release film-coated tablets

Package unit

Domestic use - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.